Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer's Disease.

Alzheimer's disease (AD) is pathologically characterized by the accumulation of β-amyloid (Aβ) deposits in the parenchymal and cortical brain. In this work, we designed, synthesized, and evaluated a series of near-infrared (NIR) probes with electron donor-acceptor end groups interacting through a π-conjugated system for the detection of Aβ deposits in the brain. Among these probes, 3b and 3c had excellent fluorescent properties (emission maxima > 650 nm and high quantum yields) and displayed high sensitivity and high affinities to Aβ aggregates (3b, Kd = 8.8 nM; 3c, Kd = 1.9 nM). Both 3b and 3c could readily penetrate the blood-brain barrier with high initial brain uptake and fast to moderate washout from the brain. In vivo NIR imaging revealed that 3b and 3c could efficiently differentiate transgenic and wild-type mice. In summary, our research provides new hints for developing smarter and more activatable NIR probes targeting Aβ.

[1]  Terence E. Rice,et al.  Signaling Recognition Events with Fluorescent Sensors and Switches , 1997 .

[2]  S. Wasik,et al.  Fluorescence measurements of benzene, naphthalene, anthracene, pyrene, fluoranthene, and benzo(e)pyrene in water. , 1976, Analytical chemistry.

[3]  J. Barrio,et al.  Molecular-Imaging Probe 2-(1-{6-[(2-Fluoroethyl)(Methyl) Amino]-2-Naphthyl}Ethylidene) Malononitrile Labels Prion Plaques In Vitro , 2003, The Journal of Neuroscience.

[4]  J. Hardy.  The shorter amyloid cascade hypothesis. , 1999, Neurobiology of Aging.

[5]  A. Martí,et al.  Unraveling the photoluminescence response of light-switching ruthenium(II) complexes bound to amyloid-β. , 2013, Journal of the American Chemical Society.

[6]  J. Olmsted.  Calorimetric determinations of absolute fluorescence quantum yields , 1979 .

[7]  H. Gutiérrez‐de‐Terán,et al.  Crystal structure of thioflavin-T and its binding to amyloid fibrils: insights at the molecular level. , 2010, Chemical communications.

[8]  R. Motter,et al.  Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.

[9]  R. Weissleder,et al.  Fluorescence molecular tomography resolves protease activity in vivo , 2002, Nature Medicine.

[10]  M. Cui,et al.  Evaluation of molecules based on the electron donor-acceptor architecture as near-infrared β-amyloidal-targeting probes. , 2014, Chemical communications.

[11]  Hiroyuki Kimura,et al.  Radioiodinated benzimidazole derivatives as single photon emission computed tomography probes for imaging of β-amyloid plaques in Alzheimer's disease. , 2011, Nuclear medicine and biology.

[12]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[13]  Yuguang Ma,et al.  Highly efficient near-infrared organic light-emitting diode based on a butterfly-shaped donor-acceptor chromophore with strong solid-state fluorescence and a large proportion of radiative excitons. , 2014, Angewandte Chemie.

[14]  J. Barrio,et al.  1,1-Dicyano-2-[6-(dimethylamino)naphthalen-2-yl]propene (DDNP): A Solvent Polarity and Viscosity Sensitive Fluorophore for Fluorescence Microscopy⊥ , 1996 .

[15]  P. Günter,et al.  Elongated push–pull diphenylpolyenes for nonlinear optics: molecular engineering of quadratic and cubic optical nonlinearities via tuning of intramolecular charge transfer , 1999 .

[16]  D. Selkoe,et al.  The origins of Alzheimer disease: a is for amyloid. , 2000, JAMA.

[17]  Tyler E. Benedum,et al.  Novel styrylpyridines as probes for SPECT imaging of amyloid plaques. , 2007, Journal of medicinal chemistry.

[18]  Y. Li,et al.  Dicyanovinylnaphthalenes for neuroimaging of amyloids and relationships of electronic structures and geometries to binding affinities , 2012, Proceedings of the National Academy of Sciences.

[19]  M F Sanner,et al.  Python: a programming language for software integration and development. , 1999, Journal of molecular graphics & modelling.

[20]  Nikolaus Grigorieff,et al.  Recent progress in understanding Alzheimer's β-amyloid structures. , 2011, Trends in biochemical sciences.

[21]  Boli Liu,et al.  Novel cyclopentadienyl tricarbonyl complexes of (99m)Tc mimicking chalcone as potential single-photon emission computed tomography imaging probes for β-amyloid plaques in brain. , 2013, Journal of medicinal chemistry.

[22]  Stefano Forli,et al.  Virtual screening with AutoDock: theory and practice , 2010, Expert opinion on drug discovery.

[23]  John Hardy,et al.  Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. , 2005, The American journal of pathology.

[24]  Peter Krämer,et al.  Intramolecular charge transfer in elongated donor-acceptor conjugated polyenes , 1995 .

[25]  Jorge Ripoll,et al.  Fluorescence Molecular Tomography: Principles and Potential for Pharmaceutical Research , 2011, Pharmaceutics.

[26]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[27]  Zhiyong Zhang,et al.  Radioiodinated benzyloxybenzene derivatives: a class of flexible ligands target to β-amyloid plaques in Alzheimer's brains. , 2014, Journal of medicinal chemistry.

[28]  Y. Duan,et al.  Dual binding modes of Congo red to amyloid protofibril surface observed in molecular dynamics simulations. , 2007, Journal of the American Chemical Society.

[29]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[30]  Brian J. Bacskai,et al.  Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy , 2001, Nature Medicine.

[31]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[32]  Tim C. Lei,et al.  Multiphoton Microscopy for Ophthalmic Imaging , 2011, Journal of ophthalmology.

[33]  Anna Moore,et al.  Design, synthesis, and testing of difluoroboron-derivatized curcumins as near-infrared probes for in vivo detection of amyloid-beta deposits. , 2009, Journal of the American Chemical Society.

[34]  Stefano Forli,et al.  A force field with discrete displaceable waters and desolvation entropy for hydrated ligand docking. , 2012, Journal of medicinal chemistry.

[35]  V. Pike,et al.  Radioligand Development for PET Imaging of β-Amyloid (Aβ)-Current Status , 2007 .

[36]  P. Thompson,et al.  PET of brain amyloid and tau in mild cognitive impairment. , 2006, The New England journal of medicine.

[37]  V. Pike,et al.  Radioligand development for PET imaging of beta-amyloid (Abeta)--current status. , 2007, Current medicinal chemistry.

[38]  Lin Zhu,et al.  PET/SPECT imaging agents for neurodegenerative diseases. , 2014, Chemical Society reviews.

[39]  Nobuhisa Iwata,et al.  19F and 1H MRI detection of amyloid beta plaques in vivo. , 2005, Nature neuroscience.

[40]  A. Becke.  Density-functional thermochemistry. III. The role of exact exchange , 1993 .

[41]  M. Frisch,et al.  Ab Initio Calculation of Vibrational Absorption and Circular Dichroism Spectra Using Density Functional Force Fields , 1994 .

[42]  N. Mataga,et al.  Solvent Effects upon Fluorescence Spectra and the Dipolemoments of Excited Molecules , 1956 .

[43]  J. Hickson.  In vivo optical imaging: preclinical applications and considerations. , 2009, Urologic oncology.

[44]  Boli Liu,et al.  Smart near-infrared fluorescence probes with donor-acceptor structure for in vivo detection of β-amyloid deposits. , 2014, Journal of the American Chemical Society.

[45]  Warren J. Hehre,et al.  Molecular orbital theory of the properties of inorganic and organometallic compounds 5. Extended basis sets for first‐row transition metals , 1987 .

[46]  Stephen Ashman,et al.  Single-Molecule Detection Technologies in Miniaturized High-Throughput Screening: Fluorescence Intensity Distribution Analysis , 2003, Journal of biomolecular screening.

[47]  Markus Rudin,et al.  In vivo detection of amyloid-β deposits by near-infrared imaging using an oxazine-derivative probe , 2005, Nature Biotechnology.

[48]  Hiroyuki Kimura,et al.  BODIPY-based molecular probe for imaging of cerebral β-amyloid plaques. , 2012, ACS chemical neuroscience.

[49]  Brian J Bacskai,et al.  Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-β ligand in transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  E. Lippert,et al.  Spektroskopische Bestimmung des Dipolmomentes aromatischer Verbindungen im ersten angeregten Singulettzustand , 1957, Zeitschrift für Elektrochemie, Berichte der Bunsengesellschaft für physikalische Chemie.

[51]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[52]  Mengchao Cui,et al.  Past and recent progress of molecular imaging probes for β-amyloid plaques in the brain. , 2013, Current medicinal chemistry.

[53]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[54]  Zeng Li,et al.  Design and synthesis of curcumin analogues for in vivo fluorescence imaging and inhibiting copper-induced cross-linking of amyloid beta species in Alzheimer's disease. , 2013, Journal of the American Chemical Society.

[55]  Chun Wu,et al.  Binding of Congo red to amyloid protofibrils of the Alzheimer Aβ(9-40) peptide probed by molecular dynamics simulations. , 2012, Biophysical journal.

[56]  Kathryn Ziegler-Graham,et al.  Forecasting the global burden of Alzheimer’s disease , 2007, Alzheimer's & Dementia.